Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$55.39 - $72.47 $167,333 - $218,931
-3,021 Reduced 48.78%
3,172 $186,000
Q4 2023

Jan 31, 2024

SELL
$37.14 - $64.82 $15,933 - $27,807
-429 Reduced 6.48%
6,193 $370,000
Q3 2023

Nov 01, 2023

BUY
$23.65 - $89.22 $4,020 - $15,167
170 Added 2.63%
6,622 $251,000
Q2 2023

Jul 31, 2023

SELL
$76.68 - $93.31 $1.11 Million - $1.36 Million
-14,522 Reduced 69.24%
6,452 $587,000
Q1 2023

May 01, 2023

BUY
$46.59 - $66.96 $106,364 - $152,869
2,283 Added 12.21%
20,974 $1.38 Million
Q4 2022

Jan 31, 2023

SELL
$43.24 - $61.04 $15,869 - $22,401
-367 Reduced 1.93%
18,691 $966,000
Q3 2022

Nov 10, 2022

BUY
$44.76 - $69.66 $103,798 - $161,541
2,319 Added 13.85%
19,058 $1.3 Million
Q2 2022

Aug 12, 2022

BUY
$35.07 - $59.21 $5,470 - $9,236
156 Added 0.94%
16,739 $757,000
Q1 2022

May 16, 2022

BUY
$35.46 - $54.12 $3,900 - $5,953
110 Added 0.67%
16,583 $843,000
Q4 2021

Feb 11, 2022

BUY
$30.74 - $49.16 $7,531 - $12,044
245 Added 1.51%
16,473 $779,000
Q3 2021

Nov 10, 2021

SELL
$31.4 - $69.84 $193,110 - $429,516
-6,150 Reduced 27.48%
16,228 $535,000
Q2 2021

Aug 12, 2021

BUY
$40.9 - $64.9 $3,231 - $5,127
79 Added 0.35%
22,378 $1.41 Million
Q1 2021

May 17, 2021

BUY
$40.8 - $57.39 $909,799 - $1.28 Million
22,299 New
22,299 $957,000

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.61B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.